Friday 04 Apr, 2025 04:11 AM
Site map | Locate Us | Login
   Dabur India drops on expecting net profit margin to decline 150-175 bps in Q4    Advait Energy surges on emerging as L1 Bidder for MVCC project    Marico expects revenue to grow in double digits in FY26    Shakti Pumps gains on bagging Rs 12-cr order from MEDA    Avanti Feeds Ltd leads losers in 'A' group    Avanti Feeds, Apex Frozen Foods slump as US tariffs may impact India's shrimp exports    Pokarna Ltd leads losers in 'B' group    Shilpa Medicare rallies on BORUZU injections launch in US    Hariom Pipe Inds soars after VAP sales rise 46% YoY in Q4; FY25 sales volume at 2,45,467 MT    Volumes jump at Vardhman Textiles Ltd counter    BSE SME Identixweb logs in to market success    ACME Solar hits the roof after securing Rs 2,491 cr refinancing project    Information Technology stocks slide    Mahindra Finance records disbursements of Rs 15,480 crore in Q4 FY25    Mahindra & Mahindra Ltd slips for fifth straight session 
Saravan Stocks
       
Company News
Hindustan Unilever Ltd
Stock Alert: Hindustan Unilever, Hindalco Inds, Glenmark Pharma, Ashoka Buildcon
Mar 21,2025   Hrs IST

Securities in F&O Ban:

Manappuram Finance, Polycab India, Hindustan Copper, IndusInd Bank and SAIL shares are banned from F&O trading on Friday, 21 March 2025.

Stocks to Watch:

Hindustan Unilever’s board approved the investment to acquire a 14.3% stake in Lucro Plastecycle, a leading player in recycled flexible plastics. The investment aims to strengthen plastic circularity by increasing the availability of recycled content for flexibles, providing a roadmap for businesses to move towards sustainable plastic packaging, and addressing the challenge of hard-to-recycle flexible plastic.

Hindalco Industries plans to invest Rs 45,000 crore across aluminium, copper, and specialty alumina businesses to deliver both upstream and next-generation high-precision engineered products.

Glenmark Pharmaceuticals’ US subsidiary, Glenmark Pharmaceuticals Inc, USA, has received final approval from the United States Food & Drug Administration (US FDA) for Olopatadine Hydrochloride Ophthalmic Solution. Olopatadine Ophthalmic is used to treat itching of the eye caused by allergic conjunctivitis (pink eye).

Tata Consultancy Services partnered with The Cumberland Building Society in the UK to modernize its core banking ecosystem. TCS will deploy its digital banking solution, TCS BaNCS for Core Banking, along with TCS Digital Home Lending Solution and Quartz for Compliance, to drive innovation and operational efficiency.

Lloyds Metal and Energy received environmental clearance for the upcoming 1.2 MTPA wire rod project and 4.0 MTPA pellet plant project in Chandrapur, Maharashtra.

Ashoka Buildcon approved the re-appointment of Satish Parakh as managing director for three years, effective April 1, and Sanjay Londhe as whole-time director for three years, effective April 1, 2025.

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 39961889
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd